CEL-SCI Corp. (CVM)

2.31 +0.22 (+10.53%) USD  |  NYAM  |  Oct 02, 16:00
2.33 +0.02 (+0.87%) After-Hours: 20:00
More

CEL-SCI Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for CVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2024 --
June 30, 2024 --
Date Value
March 31, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade
Imunon, Inc. Upgrade
Curis, Inc. Upgrade